Related Experiment Video
Updated: Aug 3, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
Molecular pathology of skin carcinogenesis due to arsenicalism from coal-burning
Chang-Jun Hu1, Ai-Hua Zhang, Hsiao-Hsin Huang
1Department of Laboratory Medicine, Huaihua Medical College, Hunan Province, People's Republic of China. hcj66@21cn.com
Abstract:
Arsenicalism has been observed throughout the world and has become an urgent public health concern. The authors explored the mechanism of carcinogenesis of inorganic arsenic in patients with arsenicalism from coal-burning pollution. The 68 subjects were divided into 3 groups--carcinoma, precarcinoma, and common-on the basis of pathological diagnosis. The expressions of proliferating cell nuclear antigen (PCNA), mutant-type P53, and B-cell lymphoma/leukemia-2 (BCL-2) proteins were detected by immunohistochemical staining. PCNA, P53, and BCL-2 proteins were overexpressed. The proteins' overexpressions correlated with the pathological changes seen in each pathological study group (i.e., common < precarcinoma < carcinoma). Statistical correlation was observed between P53 and BCL-2, and between PCNA and BCL-2. The authors concluded that cell proliferation, antiapoptosis, and up-regulation of the mutant-type P53 gene played vital roles in the pathological development of arsenicalism.
Insights
Inorganic arsenic exposure causes cancer by increasing cell proliferation and preventing cell death. Overexpression of mutant P53 and BCL-2 proteins is linked to disease progression in arsenicalism.
Area of Science:
- Environmental Health
- Oncology
- Molecular Biology
Background:
- Arsenicalism, caused by inorganic arsenic exposure, is a global public health issue.
- Coal-burning pollution is a significant source of arsenic exposure.
- Understanding arsenic's carcinogenic mechanisms is crucial for public health interventions.
Purpose of the Study:
- To investigate the molecular mechanisms of inorganic arsenic-induced carcinogenesis.
- To examine the role of specific protein expressions in the progression of arsenicalism.
- To correlate protein expression levels with pathological changes in affected tissues.
Main Methods:
- Immunohistochemical staining was used to detect protein expressions.
- Proliferating cell nuclear antigen (PCNA), mutant-type P53, and B-cell lymphoma/leukemia-2 (BCL-2) proteins were analyzed.
- Sixty-eight subjects were categorized into carcinoma, precarcinoma, and common groups based on pathological diagnosis.
Main Results:
- Overexpression of PCNA, mutant-type P53, and BCL-2 proteins was observed in patients with arsenicalism.
- Protein overexpression levels correlated positively with the severity of pathological changes (common < precarcinoma < carcinoma).
- Significant statistical correlations were found between P53 and BCL-2, and between PCNA and BCL-2.
Conclusions:
- Cell proliferation, anti-apoptosis, and mutant-type P53 gene up-regulation are key factors in arsenicalism's pathological development.
- These molecular changes contribute to the carcinogenic process initiated by inorganic arsenic.
- Findings highlight potential therapeutic targets for managing arsenic-induced diseases.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Prevention
Some...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutagenicity and Carcinogenicity

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)